Protein 1 | Protein 2 | Combine Score |
---|---|---|
FDXR | FDX1 | 0.997 |
SCP2 | FDX1 | 0.806 |
DBI | SCP2 | 0.769 |
DBI | FDX1 | 0.754 |
DBI | FDXR | 0.75 |
FDXR | SCP2 | 0.743 |
PFDN5 | DBI | 0.721 |
DBI | ACBD3 | 0.706 |
# | 2230 (FDX1) | 6342 (SCP2) | 2232 (FDXR) | 1622 (DBI) | 64746 (ACBD3) | 5204 (PFDN5) |
---|---|---|---|---|---|---|
2230 (FDX1) | 1.00 | 0.29 | 0.25 | 0.29 | 0.35 | 0.34 |
6342 (SCP2) | 0.29 | 1.00 | 0.22 | 0.69 | 0.54 | 0.48 |
2232 (FDXR) | 0.25 | 0.22 | 1.00 | 0.17 | 0.22 | 0.22 |
1622 (DBI) | 0.29 | 0.69 | 0.17 | 1.00 | 0.63 | 0.55 |
64746 (ACBD3) | 0.35 | 0.54 | 0.22 | 0.63 | 1.00 | 0.72 |
5204 (PFDN5) | 0.34 | 0.48 | 0.22 | 0.55 | 0.72 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DBI | Rat | Left brain cortices | 300hPa | 9144 m | 1 hour | upregulated | 1.41±0.1 | TMT labeled LTQ orbitrap | Southwestern europe | Male wistar rats | 1 | Adult male Wistar rats weighing 350 g | 28697276 |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|
ID | GO ID | GO Term | GO Type |
---|---|---|---|
1622 | GO:0008289 | lipid binding | GOTERM_MF_DIRECT |
1622 | GO:0046983 | protein heterodimerization activity | GOTERM_MF_DIRECT |
1622 | GO:0005783 | endoplasmic reticulum | GOTERM_CC_DIRECT |
1622 | GO:0005794 | Golgi apparatus | GOTERM_CC_DIRECT |
1622 | GO:0036151 | phosphatidylcholine acyl-chain remodeling | GOTERM_BP_DIRECT |
1622 | GO:0006810 | transport | GOTERM_BP_DIRECT |
1622 | GO:0018345 | protein palmitoylation | GOTERM_BP_DIRECT |
1622 | GO:0070062 | extracellular exosome | GOTERM_CC_DIRECT |
1622 | GO:0000062 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process | GOTERM_MF_DIRECT |
1622 | GO:0030156 | manganese ion binding | GOTERM_MF_DIRECT |
1622 | GO:0036042 | lysophosphatidic acid binding | GOTERM_MF_DIRECT |
1622 | GO:0097038 | perinuclear endoplasmic reticulum | GOTERM_CC_DIRECT |
Human Entrez ID | KEGG ID | KEGG Term |
---|---|---|
1622 | hsa03320 | PPAR signaling pathway |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
DBI | 1622 | Carcinomatosis | C0205699 | Neoplastic Process | 0.3 | 0.727 | 0.414 | phenotype |
DBI | 1622 | Animal Mammary Neoplasms | C0024667 | Neoplastic Process | 0.3 | 0.727 | 0.414 | group |
DBI | 1622 | Carcinoma | C0007097 | Neoplastic Process | 0.3 | 0.727 | 0.414 | group |
DBI | 1622 | Undifferentiated carcinoma | C0205698 | Neoplastic Process | 0.3 | 0.727 | 0.414 | phenotype |
DBI | 1622 | Anaplastic carcinoma | C0205696 | Neoplastic Process | 0.3 | 0.727 | 0.414 | disease |
DBI | 1622 | Mammary Neoplasms, Experimental | C0024668 | Experimental Model of Disease; Neoplastic Process | 0.3 | 0.727 | 0.414 | group |
DBI | 1622 | Carcinoma, Spindle-Cell | C0205697 | Neoplastic Process | 0.3 | 0.727 | 0.414 | disease |
DBI | 1622 | Mammary Carcinoma, Animal | C1257925 | Neoplastic Process | 0.3 | 0.727 | 0.414 | disease |
DBI | 1622 | Psychotic Disorders | C0033975 | Mental or Behavioral Dysfunction | 0.01 | 0.727 | 0.414 | group |
DBI | 1622 | Schizophrenia | C0036341 | Mental or Behavioral Dysfunction | 0.02 | 0.727 | 0.414 | disease |